Three-Year Outcomes After Surgical Aortic Valve Replacement With a Bioprosthetic Valve from the Multi-Centre IMPACT Registry
Interdisciplinary CardioVascular and Thoracic Surgery · 12.03.2026 · 41 (3)
DOI: 10.1093/icvts/ivag056 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, online erschienen am 05.03.2026. Verfasst von Farhad Bakhtiary und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, University Hospital Bonn, Bonn, 53127, Germany. Hauptthemen laut MEDLINE: Bioprosthesis, Heart Valve Prosthesis, Aortic Valve Stenosis, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Edwards Lifesciences, IPPMed GmbH.
Abstract (Originalsprache)
Objectives
To investigate 3-year outcomes of surgical aortic valve replacement using the INSPIRIS RESILIA aortic valve bioprosthesis in patients with severe aortic stenosis.
Methods
IMPACT registry is a prospective, multicentre, international registry with a 5-year follow-up. After 3 years, haemodynamic performance, all-cause mortality, and valve-related mortality were determined.
Results
A total of 556 patients who underwent surgical aortic valve replacement with the INSPIRIS RESILIA aortic valve were enrolled between December 2019 and June 2021. The mean age was 63.4 ± 8.5 years, 29.0% were female, with a EuroSCORE II of 2.2 ± 2.5% and an STS score of 1.7 ± 2.2%. Hypertension (66.2%), coronary artery disease (34.7%), and diabetes (18.4%) were the most common comorbidities. A total of 49.3% of patients underwent full sternotomy, 58.3% isolated aortic valve replacement. The most commonly implanted valve sizes were 23 mm (35.4%) and 25 mm (30.9%). At 3 years, overall survival was 91.0%, freedom from valve-related mortality was 97.5%, from prosthetic endocarditis 96.0%, from stroke 91.5%, from valve-related dysfunction 98.0%, from reintervention 96.2%, from structural valve deterioration stage 2 96.8%, and from stage 3 99.4%. The mean transvalvular gradient was 11.9 mmHg at 3 years, with an indexed effective orifice area of 0.8 cm2/m2. Functional class improved from 41.2% class III or IV at baseline to 5.7% at 3 years.
Conclusions
Three-year outcomes, including survival and haemodynamic and functional status after surgical aortic valve replacement using the INSPIRIS RESILIA bioprosthetic aortic valve, were reported in a real-world patient population with severe aortic stenosis. ClinicalTrials.gov NCT04053088.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Surgery, University Hospital Bonn, Bonn, 53127, Germany.
- Department of Cardiovascular and Thoracic Surgery, Medical Faculty, Johannes Kepler University Linz, Linz, 4020, Austria.
- Clinical Research Institute for Cardiovascular and Metabolic Diseases, Medical Faculty, Johannes Kepler University Linz, Linz, 4020, Austria.
- Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, 6020, Austria.
- Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, 04289, Germany.
- Department of Cardiothoracic Surgery, Helios Clinic Siegburg, Siegburg, 53721, Germany.
ORCID-Profile: Farhad Bakhtiary, Peter Benedikt, Nikolaos Bonaros, Michael Borger, Richard Feyrer, Seymur Karimli, Ka Yan Lam, Andreas Liebold, Andreas Martens, Parwis Massoudy, Andreas Vötsch, Alberto Weber, Beate Botta, Nataliya Trushina, Anjaly Vijayan, Peter Bramlage, Andreas Zierer
Förderung
- Edwards Lifesciences
- IPPMed GmbH
Zitieren
APA
Bakhtiary, F., Benedikt, P., Bonaros, N., Borger, M., Doss, M., Feyrer, R., Grünenfelder, J., Owais, T., Karimli, S., Lam, K. Y., Liebold, A., Martens, A., Massoudy, P., Batashev, I., Pöling, J., Scherner, M. P., Strauch, J., Thielmann, M., Vötsch, A., …, & Zierer, A. (2026). Three-Year Outcomes After Surgical Aortic Valve Replacement With a Bioprosthetic Valve from the Multi-Centre IMPACT Registry. Interdisciplinary CardioVascular and Thoracic Surgery, 41(3). https://doi.org/10.1093/icvts/ivag056
Vancouver
Bakhtiary F, Benedikt P, Bonaros N, Borger M, Doss M, Feyrer R, et al. Three-Year Outcomes After Surgical Aortic Valve Replacement With a Bioprosthetic Valve from the Multi-Centre IMPACT Registry. Interdisciplinary CardioVascular and Thoracic Surgery. 2026;41(3). doi:10.1093/icvts/ivag056
BibTeX
@article{Bakhtiary2026,
author = {Bakhtiary, Farhad and Benedikt, Peter and Bonaros, Nikolaos and Borger, Michael and Doss, Mirko and Feyrer, Richard and Grünenfelder, Jürg and Owais, Tamer and Karimli, Seymur and Lam, Ka Yan and Liebold, Andreas and Martens, Andreas and Massoudy, Parwis and Batashev, Islam and Pöling, Jochen and Scherner, Maximilian Philipp and Strauch, Justus and Thielmann, Matthias and Vötsch, Andreas and Walther, Thomas and Weber, Alberto and Wiesinger, Stefan and Eden, Matthias and Kammler, Jürgen and Botta, Beate and Trushina, Nataliya and Vijayan, Anjaly and Bramlage, Peter and Zierer, Andreas},
title = {Three-Year Outcomes After Surgical Aortic Valve Replacement With a Bioprosthetic Valve from the Multi-Centre IMPACT Registry},
journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
year = {2026},
volume = {41},
number = {3},
doi = {10.1093/icvts/ivag056}
}
EUVIMED